Valens™ AH 2.0

Valens AH 2.0 is a next-generation aluminium hydroxide vaccine adjuvant, engineered for high purity, superior antigen compatibility, and flexible sterile packaging options. Sterilized via irradiation, it delivers consistent quality while streamlining workflows for safe, scalable, and globally compliant vaccine development.

Engineered for performance, safety, and scalability.

Valens™ AH 2.0 is a high-performance aluminium hydroxide adjuvant containing 2% aluminium oxide,
specifically designed for human vaccines. Its positive surface charge enables efficient antigen adsorption,
enhancing antibody-mediated immune responses, and it can be combined with other components to
stimulate additional immune pathways. Part of the Valens range, it offers proven performance with
reliable, scalable supply you can trust.

  • High Purity & Low Bioburden – Sterilized via irradiation for reliable quality

  • Customizable – Flexible volumes & packaging, including sterile biobags

  • Exceptional Quality, Consistency & Scalability– produced under excipient cGMP & Ph.Eur compliant

Download our Resource Package!

By clicking submit, you confirm that you agree to the storing and processing of your personal data by SPI Pharma as described in our Privacy Policy.

Performance you can count on

Valens AH 2.0 goes beyond traditional aluminium hydroxide adjuvants with innovations that save time, reduce contamination risk, and improve scalability.

  • Custom-tailored packaging solutions (e.g., sterile biobags)
  • Proven stability & compatibility testing on demand

speak to an expert today

The SPI Pharma Advantage

  • 20+ years in vaccine adjuvants
  • SPI’s expertise, backed by strategic partnerships, powers a pipeline of innovative vaccine adjuvants
  • Secure, scalable global supply

Valens™ AH 2.0 HA - High Adsorption

Coming soon!

Speak to our experts